Showing results (1121-1130 of 1,154) with videos related to

Sort By:
Pageof 116
International Journal of Cardiology|March 31, 2025
Electrocardiogram evolution in Anderson-Fabry disease patients during follow-up in relation to specific treatment and cardiac disease progressionVanda Parisi, Raffaello Ditaranto, Nevio Taglieri, et al.
Nature|August 26, 2021
Direct observation of ultrafast hydrogen bond strengthening in liquid waterJie Yang, Riccardo Dettori, J Pedro F Nunes, et al.
Brain : a Journal of Neurology|February 21, 2025
Proprioceptive synaptic dysfunction is a key feature in mice and humans with spinal muscular atrophyChristian M Simon, Nicolas Delestrée, Jacqueline Montes, et al.
Brazilian Journal of Physical Therapy|December 8, 2019
Respiratory physical therapy techniques recommended for patients with cystic fibrosis treated in specialized centersMárcio Vinícius Fagundes Donadio, Natália Evangelista Campos, Fernanda Maria Vendrusculo, et al.
Nature Medicine|February 5, 2025
First-in-human study of epidural spinal cord stimulation in individuals with spinal muscular atrophyGenís Prat-Ortega, Scott Ensel, Serena Donadio, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|June 26, 2023
Bezafibrate reduces the damage, activation and mechanical properties of lung fibroblast cells induced by hydrogen peroxideCamille Kirinus Reghelin, Matheus Scherer Bastos, Bruno de Souza Basso, et al.
The Lancet. Microbe|October 19, 2024
Rapid multiplex PCR panel for pneumonia in hospitalised patients with suspected pneumonia in the USA: a single-centre, open-label, pragmatic, randomised controlled trialAbinash Virk, Angel P Strasburg, Kami D Kies, et al.
European Journal of Pharmacology|October 25, 2020
Therapeutic effect of uridine phosphorylase 1 (UPP1) inhibitor on liver fibrosis in vitro and in vivoElisa Feller Gonçalves da Silva, Bruna Pasqualotto Costa, Marcella Tornquist Nassr, et al.
Blood Purification|January 19, 2011
A vitamin E-coated polysulfone membrane reduces serum levels of inflammatory markers and resistance to erythropoietin-stimulating agents in hemodialysis patients: results of a randomized cross-over multicenter trialVincenzo Panichi, Alberto Rosati, Sabrina Paoletti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 17, 2018
Nine weeks versus 1 year adjuvant trastuzumab in combination with chemotherapy: final results of the phase III randomized Short-HER study‡P Conte, A Frassoldati, G Bisagni, et al.
Pageof 116